Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqi Liangxue Shengji Decoction is a traditional Chinese medicine (TCM) formula used primarily for post-surgical recovery and wound healing, particularly after percutaneous coronary intervention. The decoction is designed to "tonify qi," "cool the blood," and promote tissue regeneration according to TCM theory. Its mechanism of action involves multi-target regulation, including anti-inflammatory effects, modulation of oxidative stress, improvement of microcirculation, and promotion of angiogenesis. Preclinical studies suggest it acts through pathways related to inflammation reduction and tissue repair[1]. The specific herbal composition may vary but typically includes herbs that support these functions in TCM practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yiqi Liangxue Shengji Decoction.